Physician Profile
Based in Columbus, OH, Namrata Dhillon, MD is listed in the NPI registry under rheumatology. Namrata graduated from Northeastern Ohio University College of Medicine in 2010. Medicare claims data shows Namrata provided 82,163 services to 2,840 patients. The services billed most often include injection, tocilizumab, 1 mg, injection, golimumab, 1 mg, for intravenous use, and injection, infliximab, excludes biosimilar, 10 mg. NPI 1689988099 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
1211 DUBLIN RD
Columbus, OH 43215
170 Taylor Station Rd Ste 300
Columbus, OH 43213
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
82,163 services · 2,840 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
398 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
366 | More often than most peers in Rheumatology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
80 | As often as other peers in Rheumatology |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
74 | Less often than most peers in Rheumatology |
| Injection, tocilizumab, 1 mg | Drug given | J3262 |
37,760 | As often as other peers in Rheumatology |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
22,355 | More often than most peers in Rheumatology |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
6,849 | More often than most peers in Rheumatology |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
4,150 | Less often than most peers in Rheumatology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
3,540 | As often as other peers in Rheumatology |
| Injection, methylprednisolone acetate, 1 mg | Drug given | J1010 |
2,229 | As often as other peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Dhillon is a rheumatologist in Columbus, OH. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Dr. Dhillon is listed at 1211 Dublin Rd, Columbus, OH 43215. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (614) 486-5200. Contact the office directly to confirm availability and scheduling.
NPI registry
Dr. Dhillon's National Provider Identifier is 1689988099. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Dhillon attended Northeastern Ohio University College of Medicine, graduating in 2010. This comes from the CMS National Downloadable File.
CMS public data
Dr. Dhillon has 16 years experience. Calculated from a graduation year of 2010, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Dhillon performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as administration of chemotherapy into vein, 1 hour or less and injection of additional new drug or substance into vein, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Dhillon. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.